EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 340 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $86,000 | +11.7% | 2,772 | +48.6% | 0.00% | – |
| Q1 2022 | $77,000 | -8.3% | 1,866 | -3.6% | 0.00% | -100.0% |
| Q4 2021 | $84,000 | +25.4% | 1,936 | +45.1% | 0.00% | 0.0% |
| Q3 2021 | $67,000 | -27.2% | 1,334 | -9.0% | 0.00% | 0.0% |
| Q2 2021 | $92,000 | -39.5% | 1,466 | -10.4% | 0.00% | -50.0% |
| Q1 2021 | $152,000 | -55.9% | 1,637 | -57.5% | 0.00% | -60.0% |
| Q4 2020 | $345,000 | +807.9% | 3,855 | +985.9% | 0.01% | +400.0% |
| Q3 2020 | $38,000 | -83.2% | 355 | -87.2% | 0.00% | -75.0% |
| Q2 2020 | $226,000 | +1954.5% | 2,765 | +1162.6% | 0.00% | – |
| Q3 2019 | $11,000 | -26.7% | 219 | -28.4% | 0.00% | -100.0% |
| Q2 2019 | $15,000 | +275.0% | 306 | +302.6% | 0.00% | – |
| Q1 2019 | $4,000 | +100.0% | 76 | +81.0% | 0.00% | – |
| Q4 2018 | $2,000 | – | 42 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 119,994 | $12,399,000 | 6.09% |
| Hillcrest Asset Management LLC | 161,826 | $16,721,000 | 2.96% |
| SNYDER CAPITAL MANAGEMENT L P | 664,662 | $68,680,000 | 2.94% |
| Copper Rock Capital Partners, LLC | 83,374 | $8,615,000 | 2.91% |
| RICE HALL JAMES & ASSOCIATES, LLC | 623,132 | $64,388,000 | 2.60% |
| Tygh Capital Management, Inc. | 130,526 | $13,487,000 | 2.56% |
| PALISADE CAPITAL MANAGEMENT, LP | 428,875 | $44,316,000 | 1.31% |
| BECK CAPITAL MANAGEMENT, LLC | 22,067 | $2,280,000 | 1.29% |
| EARNEST PARTNERS LLC | 1,394,794 | $144,124,000 | 1.24% |
| DC Investments Management, LLC | 10,945 | $1,131,000 | 1.24% |